Sodium zirconium cyclosilicate (Lokelma®) accepted for restricted use within NHS Scotland

Oral sodium zirconium cyclosilicate is approved for use in adult patients with hyperkalaemia, with chronic kidney disease stage 3b to 5 and/or heart failure; who would otherwise need to down-titrate or discontinue their renin-angiotensin-aldosterone system inhibitor therapy.


Scottish Medicines Consortium